M

MoonLake Immunotherapeutics
NASDAQ:MLTX

Watchlist Manager
MoonLake Immunotherapeutics
NASDAQ:MLTX
Watchlist
Price: 51.06 USD -1.6%
Market Cap: 3.3B USD
Have any thoughts about
MoonLake Immunotherapeutics?
Write Note

MoonLake Immunotherapeutics
Total Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

MoonLake Immunotherapeutics
Total Receivables Peer Comparison

Comparables:
ADCT
ACIU
CRSP
MOLN
XLS

Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
M
MoonLake Immunotherapeutics
NASDAQ:MLTX
Total Receivables
$3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
ADC Therapeutics SA
NYSE:ADCT
Total Receivables
$25.2m
CAGR 3-Years
162%
CAGR 5-Years
71%
CAGR 10-Years
N/A
AC Immune SA
NASDAQ:ACIU
Total Receivables
CHf1.6m
CAGR 3-Years
20%
CAGR 5-Years
-2%
CAGR 10-Years
N/A
CRISPR Therapeutics AG
NASDAQ:CRSP
Total Receivables
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Molecular Partners AG
SIX:MOLN
Total Receivables
CHf3.4m
CAGR 3-Years
-25%
CAGR 5-Years
9%
CAGR 10-Years
N/A
Xlife Sciences AG
SIX:XLS
Total Receivables
CHf17.9m
CAGR 3-Years
292%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is MoonLake Immunotherapeutics's Total Receivables?
Total Receivables
3m USD

Based on the financial report for Dec 31, 2023, MoonLake Immunotherapeutics's Total Receivables amounts to 3m USD.

What is MoonLake Immunotherapeutics's Total Receivables growth rate?
Total Receivables CAGR 1Y
-27%

Over the last year, the Total Receivables growth was -27%.

Back to Top